University of Minnesota. Driven to Discover.
Panel gives a preference to Shingrix and recommends MMR for mumps outbreaks.
Overall flu vaccine effectiveness was 48%, but a change in the 2009 H1N1 vaccine strain didn't fix the problem with the inhaled vaccine's effectiveness in children.
The vaccine offers strong protection to infants, especially during the first 2 months of life.
Healthcare providers need to offer vaccines and address vaccine hesitancy whenever possible, the AAP's Committee on Infectious Diseases says.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.